Abstract #0218

Quantitative assessment of cerebrovascular reactivity in older individuals: relationship to diagnosis, cognition and physical function

Sandeepa Sur¹, Zixuan Lin¹, Yang Li¹, Sevil Yasar², Paul Rosenberg³, Abhay Moghekar⁴, Shruti Agarwal¹, Xirui Hou¹, Rita Kalyani⁵, Kaisha Hazel¹, George Pottanat¹, Cuimei Xu¹, Peter van Zijl⁶, Jay Pillai⁷, Peiying Liu¹, Marilyn Albert⁴, and Hanzhang Lu¹

¹Department of Radiology, Johns Hopkins University, Baltimore, MD, United States, ²Department of Gerontology, Johns Hopkins University, Baltimore, MD, United States, ³Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, baltimore, MD, United States, ⁴Department of Neurology, Johns Hopkins University, Baltimore, MD, United States, ⁵Department of Medicine, Johns Hopkins University, Baltimore, MD, United States, ⁶F.M. Kirby Research Center, Kennedy Krieger Institute, baltimore, MD, United States, ⁷Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, United States

This study addresses the question, whether quantitative cerebrovascular reactivity (CVR) is a potential vascular biomarker in dementia with Alzheimer’s and vascular pathologies. This was tested in a cross-sectional study, where CBF-CVR assessed via Phase-Contrast-MRI during a CO₂ breathing-challenge predicted cognitive and functional performance, disease-severity, and diabetes-risk, in 67 normal and mild-cognitive-impairment subjects. The performance and severity relationships remained robust after adjusting for Alzheimer’s disease and competing vascular markers. These findings suggest that quantitative CBF-CVR has potential as a sensitive biomarker for early changes in cognitive and functional performance, and of disease severity in dementia, independent of Alzheimer’s disease.

This abstract and the presentation materials are available to members only; a login is required.

Join Here